IP Library Granted Patent US 12698510
Granted Patent B2
US 12698510 · App. 19/193,742 · Granted Aug 4, 2026

DNA origami encoding for gene expression and contransfection

Inventors: Jessica Kretzmann (Manning, AU); Hendrik Dietz (Haar, DE)
Assignee: Technische Universität München
C12N15/85C12N15/87C12N2310/531C12N2830/42C12N2830/48C12N2830/50
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 12698510
App. No.
19/193,742
Filed
Apr 29, 2025
Granted
Aug 4, 2026
Kind
B2
Art Unit
1636
USPC
514/44R
Abstract

The present invention relates to a nucleic acid nanostructure comprising at least one scaffold strand and a plurality of staple strands, wherein said nanostructure, preferably said at least one scaffold strand, comprises at least one nucleic acid sequence encoding a gene. The present invention further relates to a composition comprising a nucleic acid nanostructure, and to a collection of nucleic acid sequences or collection of plasmids encoding a nucleic acid nanostructure. Furthermore, the present invention relates to a nucleic acid nanostructure or composition comprising a nucleic acid nanostructure for use in medicine; preferably for use in a method of preventing, treating and/or diagnosing a disease or disorder. The present invention also relates to a method of expressing a gene from a nucleic acid nanostructure, and to a use of a nanostructure or of a composition for gene expression.

Claims (19)

1 . A nucleic acid nanostructure for expression of a target gene in a eukaryotic cell comprising:

(a) a single-stranded DNA (ssDNA) scaffold strand that comprises an expression cassette comprising at least one nucleic acid sequence encoding the target gene, a promoter, a terminator, and a polyadenylation signal sequence, and

(b) at least one enhancer staple that comprises a sequence that binds to the ssDNA scaffold strand and upon binding enhances expression of the target gene when the nucleic acid nanostructure is inserted into the eukaryotic cell, as compared to a nucleic acid nanostructure without the enhancer staple,

wherein the at least one enhancer staple binds to the ssDNA scaffold strand at a start region of the promoter and at the polyadenylation signal sequence; whereby when the at least one enhancer staple binds to both the start region of the promoter and the polyadenylation signal sequence, the single enhancer staple acts as a splint that brings together the start region of the promoter and the polyadenylation signal sequence.

2 . The nucleic acid nanostructure according to claim 1 , wherein said ssDNA scaffold strand comprises a plurality of nucleic acid sequences encoding a plurality of target genes.

3 . The nucleic acid nanostructure according to claim 1 , wherein said nucleic acid nanostructure comprises a first subunit and a second subunit that each independently comprise a nucleic acid sequence encoding a first target gene and a second target gene, respectively.

4 . The nucleic acid nanostructure according to claim 1 , wherein the at least one enhancer staple has a length ranging from about 60 to about 250 nucleic acid bases.

5 . The nucleic acid nanostructure according to claim 1 , wherein said ssDNA scaffold strand further comprises (a) an inverted terminal repeat nucleic acid that forms a hairpin, wherein the inverted terminal repeat nucleic acid sequence is positioned upstream or downstream of the expression cassette; or (b) an inverted terminal repeat nucleic acid sequence binding site positioned upstream and downstream of the expression cassette.

6 . The nucleic acid nanostructure according to claim 5 , wherein said ssDNA scaffold strand further comprises said inverted terminal repeat nucleic acid sequence that forms the hairpin, wherein formation of said hairpin results in increased expression of the target gene, as compared to an amount of expression in an otherwise comparable nanostructure that comprises an ssDNA scaffold strand without the inverted terminal repeat nucleic acid sequence that forms the hairpin.

7 . The nucleic acid nanostructure according to claim 5 , wherein said ssDNA scaffold strand further comprises an intron, a DNA nuclear targeting sequence, a Kozak sequence, or a woodchuck hepatitis virus posttranscriptional regulatory element.

8 . The nucleic acid nanostructure according to claim 1 , wherein said ssDNA scaffold strand comprises a nuclear targeting sequence.

9 . The nucleic acid nanostructure according to claim 8 , wherein said ssDNA scaffold strand further comprises an intron, a kozak sequence, or a woodchuck hepatitis virus posttranscriptional regulatory element.

10 . The nucleic acid nanostructure of claim 1 , wherein the nucleic acid nanostructure comprises a first enhancer staple that binds to the ssDNA scaffold strand at the start region of the promoter and a second enhancer staple that binds to the ssDNA scaffold strand at the polyadenylation signal sequence.

11 . A composition comprising the nucleic acid nanostructure according to claim 1 .

12 . A plasmid encoding the nucleic acid nanostructure according to claim 1 .

13 . A method of expressing a gene from a nucleic acid nanostructure comprising:

i) providing the nucleic acid nanostructure of claim 1 ;

ii) delivering said nucleic acid nanostructure provided in step i) to a cell; wherein said delivering comprises transfecting or transforming said cell; and

iii) allowing said cell to express said gene.